TScan Therapeutics's market cap is currently $104.42M. The company's EPS TTM is $-0.28; its P/E ratio is ―; TScan Therapeutics is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
